In the current study, we found that the frequencies of HLA-A*02:06, B*13:01 and B*40:01 were lower in the NSCLC group than in the healthy control group (0.018 vs. 0.053, 0.046 vs. 0.090 and 0.081 vs. 0.124, respectively) (Table 2), though there were no differences between the two groups after FDR correction. The gene discussed is HLA-A; the disease is non-small cell lung carcinoma.